Hikma Pharmaceuticals PLC - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
HKMPY Over the counter 2830 www.hikma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals H1 Earnings Call Highlights - Aug 6th, 2026 4:04 am
Hikma jumps 10% as brokers point to profit beat and undemanding rating - Aug 6th, 2026 3:30 am
Hikma and Fresenius best positioned from Trump's generic drug tariffs, says Citi - Jul 23rd, 2026 6:17 am
Hikma recovery story still has further to run after recent rally, says Panmure - Jul 22nd, 2026 9:13 am
Citi starts Hikma at 'buy' with strategy reset offering compelling entry point - Jul 16th, 2026 5:02 am
[Latest] Global Generic Drug Market Size/Share Worth USD 926.54 Billion by 2034 at a 6.55% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - Jun 8th, 2026 10:30 pm
Generic drugmakers gain key victory in ‘skinny label’ patent case - Jun 5th, 2026 5:51 am
Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma - Jun 4th, 2026 3:39 pm
Hikma Pharmaceuticals Announces Major Expansion in Ohio, Creating 350 New Jobs and Investing $267 Million - Jun 1st, 2026 11:19 am
How The Hikma Pharmaceuticals (LSE:HIK) Narrative Is Shifting After Analyst Valuation Resets - May 18th, 2026 10:36 pm
Pfizer (PFE) Reaches Settlement to Extend VYNDAMAX Patent Protection Until 2031 - Apr 30th, 2026 6:47 am
Pfizer protects $6.4bn heart disease blockbuster from generics, for now - Apr 29th, 2026 10:59 am
Pfizer deals extend patent life for a top-selling rare disease drug - Apr 28th, 2026 6:28 am
Hikma Pharmaceuticals Reiterates 2026 Guidance, Exits 503B Compounding in April Trading Update Call - Apr 24th, 2026 2:22 am
How The Hikma Pharmaceuticals (LSE:HIK) Narrative Is Shifting With Reset Valuations And Buybacks - Apr 21st, 2026 6:06 am
How The Investment Story On Hikma Pharmaceuticals (LSE:HIK) Is Shifting With New Targets And News - Apr 3rd, 2026 11:09 am
How The Hikma Pharmaceuticals (LSE:HIK) Narrative Is Shifting As Analyst Targets Reset - Mar 20th, 2026 1:07 am
How The Hikma Pharmaceuticals (LSE:HIK) Investment Story Is Shifting As Analyst Views Diverge - Mar 5th, 2026 5:17 am
Collegium Pharmaceutical, Inc. Q4 2025 Earnings Call Summary - Feb 26th, 2026 2:32 pm
Hikma Pharmaceuticals PLC (HKMPF) Full Year 2025 Earnings Call Highlights: Strong EBITDA ... - Feb 26th, 2026 10:02 am